-
Berotralstat effectiveness and safety in patients with hereditary angioedema with normal C1 inhibitor
Hereditary Angioedema (HAE)
-
Oral berotralstat for hereditary angioedema prophylaxis in patients aged 2 to <12 years
Hereditary Angioedema (HAE)
-
Long-term safety and efficacy of once-daily berotralstat in patients with hereditary angioedema
Hereditary Angioedema (HAE)
-
The Multifactorial Impact of Receiving a Hereditary Angioedema Diagnosis
Hereditary Angioedema (HAE)
-
Caregivers’ Role in Managing Hereditary Angioedema and Perceptions of Treatment-Related Burdens
Hereditary Angioedema (HAE)
This website is intended for US healthcare professionals only.
